Building Kento: From Episodic to Continuous, Ultra-Precise Heart Care
Building Kento: From Episodic to Continuous, Ultra-Precise Heart Care
Bringing heart care 10 years forward with daily adaptive programs and real-time support
Please join us for an ECHO webinar featuring Max Leca, who will provide an overview of Kento Health, its technologies and the story behind its success.
Date & Time: Tuesday, May 27, 2025 (11 am – 12 pm ET)
Kento Health is an early-stage digital therapeutics company co-developed with Mayo Clinic, focused on transforming cardiac rehab and secondary prevention. It delivers continuous, ultra-precise care through daily adaptive programs, real-time monitoring, and clinician support tools, turning medical guidance into lasting behavior change.
Register in advance for this webinar. After registering, you will receive a confirmation email containing information about joining the webinar.
Speaker Biography
Max Leca
Co-Founder & CEO, Kento Health
Max Leca’s family history of heart disease drives his race to build the tools he wishes his loved ones had - tools that give anyone with heart disease a better shot at a longer, healthier life. A repeat entrepreneur, Max scaled Dialogue Health’s clinical operations from zero to 1,000 staff, helping take the company public in 2021. Earlier, he founded ALTEN Canada and grew it from scratch to $40 million in revenue within a few years. He’s known for assembling purpose driven teams that execute with intensity.
Today, he leads Kento Health, delivering continuous, AI powered cardiac care that finally connects clinical guidelines to everyday life. Based in Montréal with his wife and young son, Max also owns a CrossFit gym and still coaches - staying close to his passion for movement, longevity, and helping people reach their full potential.
About Kento Health
Kento Health is an early-stage digital therapeutics company co-developed with Mayo Clinic, focused on transforming cardiac rehab and secondary prevention. It delivers continuous, ultra-precise care through daily adaptive programs, real-time monitoring, and clinician support tools, turning medical guidance into lasting behavior change. Built on the belief that real outcomes come from daily actions, Kento brings heart care 10 years forward by making it proactive, personalized, and scalable. Backed by $8M in seed funding, Kento is redefining the standard of care for millions living with heart disease.
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i). For more information, visit: https://tedrogersresearch.ca/echo/Biography
